74 related articles for article (PubMed ID: 3887329)
1. [Venous occlusive disease of the liver and autologous bone marrow transplantation. Preventive role for heparin?].
Cahn JY; Flesch M; Plouvier E; Hervé P; Rozenbaum A
Nouv Rev Fr Hematol (1978); 1985; 27(1):27-8. PubMed ID: 3887329
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
Rosenthal J; Sender L; Secola R; Killen R; Millerick M; Murphy L; Cairo MS
Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013
[TBL] [Abstract][Full Text] [Related]
3. [Veno-occlusive disease after bone marrow transplantation: preventive effect of heparin].
Parquet N; Devergie A; Socié G; Ribaud P; Espérou H; Gluckman E
Ann Med Interne (Paris); 1997; 148(2):132-5. PubMed ID: 9238437
[TBL] [Abstract][Full Text] [Related]
4. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
[TBL] [Abstract][Full Text] [Related]
5. Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin.
Simon M; Hahn T; Ford LA; Anderson B; Swinnich D; Baer MR; Bambach B; Bernstein SH; Bernstein ZP; Czuczman MS; Slack JL; Wetzler M; Herzig G; Schriber J; McCarthy PL
Bone Marrow Transplant; 2001 Mar; 27(6):627-33. PubMed ID: 11319593
[TBL] [Abstract][Full Text] [Related]
6. Veno-occlusive disease prophylaxis with fresh frozen plasma and heparin in bone marrow transplantation.
Batsis I; Yannaki E; Kaloyannidis P; Sakellari I; Smias C; Georgoulis I; Fassas A; Anagnostopoulos A
Thromb Res; 2006; 118(5):611-8. PubMed ID: 16330084
[TBL] [Abstract][Full Text] [Related]
7. Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
Klaesson S; Ringdén O; Ljungman P; Aschan J; Hägglund H; Winiarski J
Transplantation; 1995 Dec; 60(11):1225-30. PubMed ID: 8525515
[TBL] [Abstract][Full Text] [Related]
8. Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation.
Salat C; Holler E; Wolf C; Kolb HJ; Reinhardt B; Pihusch R; Krämling HJ; Heinemann V; Haller M; Hiller E
Bone Marrow Transplant; 1997 Mar; 19(5):487-90. PubMed ID: 9052916
[TBL] [Abstract][Full Text] [Related]
9. Malignancy-associated pulmonary veno-occlusive disease: report of a case following autologous bone marrow transplantation and review.
Salzman D; Adkins DR; Craig F; Freytes C; LeMaistre CF
Bone Marrow Transplant; 1996 Oct; 18(4):755-60. PubMed ID: 8899191
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.
Rozman C; Carreras E; Qian C; Gale RP; Bortin MM; Rowlings PA; Ash RC; Champlin RE; Henslee-Downey PJ; Herzig RH; Hinterberger W; Klein JP; Prentice HG; Reiffers J; Zwaan FE; Horowitz MM
Bone Marrow Transplant; 1996 Jan; 17(1):75-80. PubMed ID: 8673059
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.
Remberger M; Ringdén O
Transplantation; 1995 Dec; 60(11):1293-9. PubMed ID: 8525524
[TBL] [Abstract][Full Text] [Related]
12. Veno-occlusive disease of the liver in children with solid tumors undergoing autologous hematopoietic progenitor cell transplantation: a high incidence in patients with neuroblastoma.
Horn B; Reiss U; Matthay K; McMillan A; Cowan M
Bone Marrow Transplant; 2002 Mar; 29(5):409-15. PubMed ID: 11919731
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation.
Marsa-Vila L; Gorin NC; Laporte JP; Labopin M; Dupuy-Montbrun MC; Fouillard L; Isnard F; Najman A
Eur J Haematol; 1991 Nov; 47(5):346-54. PubMed ID: 1761121
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone marrow transplantation.
Schryber S; Lacasse CR; Barton-Burke M
Oncol Nurs Forum; 1987; 14(4):74-80. PubMed ID: 3299284
[No Abstract] [Full Text] [Related]
15. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia].
Huang H; Lin M; Meng H
Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):263-7. PubMed ID: 11798883
[TBL] [Abstract][Full Text] [Related]
16. Reduced mortality following bone marrow transplantation for breast cancer with the addition of peripheral blood progenitor cells is due to a marked reduction in veno-occlusive disease of the liver.
Fisher DC; Vredenburgh JJ; Petros WP; Hussein A; Berry DA; Elkordy M; Rubin P; Gilbert CJ; Peters WP
Bone Marrow Transplant; 1998 Jan; 21(2):117-22. PubMed ID: 9489626
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.
Schlitt HJ; Tischler HJ; Ringe B; Raddatz G; Maschek H; Dietrich H; Kuse E; Pichlmayr R; Link H
Bone Marrow Transplant; 1995 Sep; 16(3):473-8. PubMed ID: 8535323
[TBL] [Abstract][Full Text] [Related]
18. Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection.
Moscardó F; Sanz GF; de La Rubia J; Jiménez C; Saavedra S; Regadera A; Andreu R; García I; Plumé G; Martínez J; Martín G; Jarque I; Sanz MA
Bone Marrow Transplant; 2001 May; 27(9):983-8. PubMed ID: 11436110
[TBL] [Abstract][Full Text] [Related]
19. [A trial use of prostaglandin E1 for prevention of hepatic veno-occlusive disease after allogeneic bone marrow transplantation].
Morio S; Oh H; Kogure K; Ishii H; Ishii A; Nakaseko C; Ikegami T; Kawano E; Matsuura Y; Nishimura M
Rinsho Ketsueki; 1994 Sep; 35(9):846-52. PubMed ID: 7967053
[TBL] [Abstract][Full Text] [Related]
20. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
